NCT03897036 2025-05-20Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)Senhwa Biosciences, Inc.Phase 1 Completed25 enrolled 9 charts